Omar Aleter, in Cleveland, OH - Medicare Student in an Organized Health Care Education/Training Program

Omar Aleter, is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Cleveland, Ohio. His current practice location is 9500 Euclid Ave # Na23, Cleveland, Ohio. You can reach out to his office (for appointments etc.) via phone at (216) 444-2200.

Omar Aleter is licensed to practice in Ohio (license number 57.249865) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1033663323.

Contact Information

	Omar Aleter,
	9500 Euclid Ave # Na23, Cleveland, OH 44195-5302
	(216) 444-2200
	Not Available

Physician's Profile

Full Name	Omar Aleter
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	9500 Euclid Ave # Na23, Cleveland, Ohio
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033663323
Provider Enumeration Date: 08/04/2016
Last Update Date: 06/10/2020

Medicare PECOS Information:

PECOS PAC ID: 3870872013
Enrollment ID: I20161111000103

Medical Identifiers

Medical identifiers for Omar Aleter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033663323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RN0300X	Internal Medicine - Nephrology	BP10055882 (Texas)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	57.249865 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Omar Aleter is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Omar Aleter, 9500 Euclid Ave # Na-23, Cleveland, OH 44195-5302 Ph: (216) 444-2200	Omar Aleter, 9500 Euclid Ave # Na23, Cleveland, OH 44195-5302 Ph: (216) 444-2200

News Archive

Estrogen modestly protective against COVID-19?

Almost from the beginning, scientists have been struck by the disproportionately higher numbers of men and older adults who have developed severe COVID-19 disease compared to younger individuals and women. Prior research has shown that in 37 of the 38 countries from which sex-stratified data was available, males were at a higher risk of death. Also, post-menopausal women are at increased risk of severe COVID-19. However, the biological underpinnings of this have been less visible.

Proprietary Novozymes technology used in GlaxoSmithKline's new diabetes treatment

Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.

Early symptoms of Parkinson's disease may be revealed in dream sleep

During a large-scale study of the socioeconomic costs of this neurodegenerative disease, Danish researchers, some from the University of Copenhagen, discovered that very early symptoms of Parkinson's disease may be revealed in dream or REM sleep.

Unprecedented detailed description of MAP kinase complex structure

In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.

Study finds increase in drinking among people with anxiety and depression during COVID-19

People with anxiety and depression are more likely to report an increase in drinking during the COVID-19 pandemic than those without mental health issues, according to a new study by researchers at NYU School of Global Public Health published in the journal Preventive Medicine.

Omar Aleter, - Medicare Student in an Organized Health Care Education/Training Program in Cleveland, OH